secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001628280-25-008444
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel reports record Q4 gross margin 78%, FY2024 revenue up 20% to $237M, net income positive
--------------------------------------------------------------------------------

- Full-year 2024 revenue $237.2M (+20% YoY); MACI $197.3M (+20%), Burn Care $39.9M (+22%).
- Q4 GAAP net income $19.8M ($0.38 diluted EPS) vs $13.0M YoY; adjusted EBITDA margin 40%.
- FY2024 adjusted EBITDA $53.4M (23% margin), up 58% YoY; operating cash flow $58.2M.
- 2025 guidance: revenue growth 20-23%, gross margin 73-74%, adj. EBITDA margin 25-26%.
- MACI Arthro launch traction: ~250 surgeons trained; NexoBrid orders +42% QoQ; new facility on track.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828025008444/0001628280-25-008444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828025008444/vcel-20250227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-008444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer